Bolt Biotherapeutics (BOLT) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free BOLT Stock Alerts $1.11 -0.05 (-4.31%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Bolt Biotherapeutics Short Interest DataCurrent Short Volume2,080,000 sharesPrevious Short Volume1,970,000 sharesChange Vs. Previous Month+5.58%Dollar Volume Sold Short$2.35 millionShort Interest Ratio / Days to Cover16.2Last Record DateApril 15, 2024Outstanding Shares38,130,000 sharesFloat Size24,090,000 sharesShort Percent of Float8.63%Today's Trading Volume122,489 sharesAverage Trading Volume113,389 sharesToday's Volume Vs. Average108% Short Selling Bolt Biotherapeutics ? Sign up to receive the latest short interest report for Bolt Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBOLT Short Interest Over TimeBOLT Days to Cover Over TimeBOLT Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Bolt Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,080,000 shares $2.35 million +5.6%8.6%16.2 $1.13 3/31/20241,970,000 shares $2.76 million +0.5%8.2%16.3 $1.40 3/15/20241,960,000 shares $2.18 million +12.6%8.2%15.6 $1.11 2/29/20241,740,000 shares $1.98 million +7.4%7.3%13.7 $1.14 2/15/20241,620,000 shares $1.83 million No Change6.8%13.6 $1.13 1/31/20241,620,000 shares $1.64 million -1.2%6.8%15.1 $1.01 Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,640,000 shares $1.89 million No Change6.7%15.9 $1.15 12/31/20231,640,000 shares $1.84 million -0.6%6.7%15.5 $1.12 12/15/20231,650,000 shares $1.77 million +0.6%6.7%12.2 $1.07 11/30/20231,640,000 shares $1.40 million No Change6.7%13.9 $0.85 11/15/20231,640,000 shares $1.61 million +2.5%6.7%14.6 $0.98 10/31/20231,600,000 shares $1.57 million -3.0%6.6%14.6 $0.98 10/15/20231,650,000 shares $1.58 million +5.8%7.0%14.2 $0.96 9/30/20231,560,000 shares $1.62 million +0.7%6.6%13.8 $1.04 9/15/20231,550,000 shares $1.69 million +3.3%6.6%20.1 $1.09 8/31/20231,500,000 shares $1.65 million -12.3%6.4%16.1 $1.10 8/15/20231,710,000 shares $2.12 million +3.6%7.3%16.4 $1.24 7/31/20231,650,000 shares $2.23 million +5.8%7.0%12.3 $1.35 7/15/20231,560,000 shares $2.12 million +0.7%6.7%10.7 $1.36 6/30/20231,550,000 shares $1.98 million No Change6.6%9.6 $1.28 6/15/20231,550,000 shares $2.34 million +2.0%6.6%7 $1.51 5/31/20231,520,000 shares $2.61 million +1.3%6.5%6.8 $1.72 5/15/20231,500,000 shares $2.93 million No Change6.4%6.3 $1.95 4/30/20231,500,000 shares $2.37 million +0.7%6.2%6 $1.58 4/15/20231,490,000 shares $2.18 million -4.5%6.2%5.9 $1.46 3/31/20231,560,000 shares $2.17 million +4.0%6.5%6.3 $1.39 3/15/20231,500,000 shares $2.19 million No Change6.2%5.3 $1.46 2/28/20231,500,000 shares $2.42 million -11.8%6.2%5.2 $1.61 2/15/20231,700,000 shares $2.38 million +0.6%7.1%5.8 $1.40 1/31/20231,690,000 shares $2.48 million +0.6%7.0%5.8 $1.47 1/15/20231,680,000 shares $2.52 million -3.5%7.0%6 $1.50 12/30/20221,740,000 shares $2.26 million -1.1%7.2%6.6 $1.30 12/15/20221,760,000 shares $2.32 million -1.7%8.6%10.1 $1.32 11/30/20221,790,000 shares $2.65 million +9.2%8.8%11 $1.48 11/15/20221,640,000 shares $2.10 million +43.9%8.1%11.9 $1.28 10/31/20221,140,000 shares $1.58 million +3.6%5.4%10.3 $1.39 10/15/20221,100,000 shares $1.54 million -1.8%5.2%10 $1.40 9/30/20221,120,000 shares $1.66 million +18.1%5.3%8.9 $1.48 9/15/2022948,500 shares $1.72 million +29.2%4.5%4.9 $1.81 8/31/2022734,300 shares $1.32 million +5.5%3.5%3.3 $1.80The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 BOLT Short Interest - Frequently Asked Questions What is Bolt Biotherapeutics' current short interest? Short interest is the volume of Bolt Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,080,000 shares of BOLT short. 8.63% of Bolt Biotherapeutics' shares are currently sold short. Learn More on Bolt Biotherapeutics' current short interest. What is a good short interest ratio for Bolt Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOLT shares currently have a short interest ratio of 16.0. Learn More on Bolt Biotherapeutics's short interest ratio. What is a good short interest percentage for Bolt Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.63% of Bolt Biotherapeutics' floating shares are currently sold short. Is Bolt Biotherapeutics' short interest increasing or decreasing? Bolt Biotherapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,080,000 shares, an increase of 5.6% from the previous total of 1,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bolt Biotherapeutics' float size? Bolt Biotherapeutics currently has issued a total of 38,130,000 shares. Some of Bolt Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bolt Biotherapeutics currently has a public float of 24,090,000 shares. How does Bolt Biotherapeutics' short interest compare to its competitors? 8.63% of Bolt Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bolt Biotherapeutics: Fortress Biotech, Inc. (13.02%), Emergent BioSolutions Inc. (11.76%), Regulus Therapeutics Inc. (10.92%), NextCure, Inc. (0.54%), Apollomics, Inc. (0.32%), Clene Inc. (0.12%), Rockwell Medical, Inc. (2.40%), Aadi Bioscience, Inc. (6.31%), Marker Therapeutics, Inc. (1.00%), ProMIS Neurosciences, Inc. (0.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Bolt Biotherapeutics stock? Short selling BOLT is an investing strategy that aims to generate trading profit from Bolt Biotherapeutics as its price is falling. BOLT shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bolt Biotherapeutics? A short squeeze for Bolt Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BOLT, which in turn drives the price of the stock up even further. How often is Bolt Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOLT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Fortress Biotech Short Interest Emergent BioSolutions Short Interest Regulus Therapeutics Short Interest NextCure Short Interest Apollomics Short Interest Clene Short Interest Rockwell Medical Short Interest Aadi Bioscience Short Interest Marker Therapeutics Short Interest ProMIS Neurosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BOLT) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace